Your GLP-1 approach, optimized for your workforce: Better outcomes, lower costs

‍At Form Health, our solutions are tailored to each workforce. Form Health offers access to flexible solutions for employers exploring full GLP-1 coverage, cash-pay options, or direct-to-employer programs through leading pharmaceutical partners. This gives employers a streamlined way to provide employees with clinical obesity care and access to GLP-1s and other anti-obesity medications (AOMs) via Form Health’s virtual Obesity Center of Excellence. We create flexible pathways to manage medication costs while providing the wraparound support that ensures best-in-class clinical outcomes.

Obesity is a chronic disease that should be treated like any other chronic condition. When left untreated, it increases the risk of costly cardiometabolic conditions such as type 2 diabetes and heart disease, resulting in annual medical costs nearly twice as high¹ and indirect costs from lost productivity up to 2.4 times higher.² By providing access to evidence-based clinical obesity and cardiometabolic care, including employer-direct GLP-1 options, employers can implement a targeted solution that addresses the condition at its root, improving employee health, reducing downstream healthcare costs, and fostering a more productive, high-performing workforce.